Two new drugs give hope to melanoma patients
NBC NEWS — Two new drugs for late-stage melanoma are giving both doctors and patients hope in the fight against their disease.
Studies show the first drug, Yervoy helped patients live two months longer than those given chemotherapy alone.
The second drug, Vemurafenib, reduced the risk of dying in certain patients by more than sixty percent, and was shown to shrink tumor size.
Experts say the drugs are promising, but not perfect. Less than half of melanoma patients will have a positive reaction.